Another private takeover: Alliance Pharma offered £350m Business The London Stock Exchange is facing yet another private takeover, with Alliance Pharma offered £349.7m in an all-cash deal. The AIM-listed firm, which sells over-the-counter drugs in over 100 countries, has seen its board recommend the takeover unanimously by asset manager DBAY Advisors and Edmond de Rothschild’s ERES IV fund. The group’s stock price jumped [...]
Alliance Pharma sees profit and revenue spike amid ongoing uncertainty Pharma Alliance Pharma has hailed its strong second half performance for helping it to record sales and additional profit expansion in its preliminary results despite the healthcare group having delayed its audited results three times this year.